My Blog
Food

Brazilian judge cuts $2.1 billion off JBS owner’s bribery fines

Brazilian judge cuts .1 billion off JBS owner’s bribery fines
Brazilian judge cuts .1 billion off JBS owner’s bribery fines


Did you get something big for Christmas?  Big?!!  I bet it was not as big as the gift a Brazilian Supreme Court judge gave J&F, the family investment firm that controls the world’s largest meatpacker, JBS.

Right before Christmas, a Brazilian Supreme Court justice suspended $10.3 billion or about $2.1 billion U.S. of fines imposed under a 2017 “leniency agreement” that J&F had reached with the government of Brazil.

Joesley and Wesley Batista, which control JBS through  J&F investments, admitted in a plea bargain to paying about $180 million in bribes to numerous Brazilian officials, including those providing state-backed financing and food safety regulators. 

The plea bargain included fines totaling $3.2 billion.  The court ruled the payments could be suspended because J&F has adhered to the 2017 agreement with federal prosecutors. J&F asked for the suspension, saying the prosecutors were biased and had taken “clearly persecutory actions.”

J&F Investments is the controlling shareholder in JBS. SA. It employs more than 250,000 people in 190 countries, including those in North America employed by the Greeley, CO-based JBS, USA.

Dias Toffoli is the high court judge who reduced the fine.  It’s unclear if the reduction is below the amount the Batistas have already paid.  J&F reportedly has paid 2.9 billion reals or $593 million toward the original total fine.

Some of the financing backed by Brazil helped JBS expand in the United States.  It purchased Swift and Company in a $1.5 billion all-cash deal on July 12, 2007.

(To sign up for a free subscription to Food Safety News, click here.) ori

Related posts

Outside Lands 2023: All the Restaurants and Bars to Expect at the San Francisco Music Festival

newsconquest

Kraft Heinz names Pedro Navio president of North American operations

newsconquest

Are you ready to answer the U.S. FDA call for traceability?

newsconquest